News | Mammography | September 09, 2015

Loyola Medicine Conducts Successful See, Test & Treat Free Cancer Screening

Event funded by the College of American Pathologists Foundation helps vulnerable women in underserved communities improve their health

Loyola University Medical Center, See Test & Treat, free cancer screening, CAP Foundation

September 9, 2015 — More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center. Funded by a grant from the College of American Pathologists (CAP) Foundation, this was the first See, Test & Treat program offered in Illinois.

“Many of the women we cared for had not had a Pap test or mammogram in more than 20 years, and thanks to the generous funding by the CAP Foundation, were able to receive care,” said Loyola Chair of Pathology Eva M. Wojcik, M.D., FCAP. “Seeing those signs of relief on the faces of women who were told their screenings came back normal was priceless.”

Wojcik led a team of more than 35 Loyola physicians and medical personnel for the cancer screenings. Women between the ages of 30 and 64 with Medicaid or who were uninsured qualified for the event.

The screening included a pelvic exam, a Pap test with same-day results, an HPV test, a breast exam and screening mammography, if appropriate. Displays and educational materials were also available to help women better understand their unique health needs. Financial and medical specialists were onsite to interact with participants, answer questions and provide information.

Through pathologists at select institutions around the United States, the See, Test & Treat program has provided free cervical and breast cancer screenings to thousands of women. The program is funded by donations to the CAP Foundation. The CAP Foundation plans to expand See, Test & Treat so that more pathologists can collaborate with their clinical colleagues to coordinate care teams and provide essential screening services to more vulnerable women across the country.

The Loyola University Medical Center event was also supported by Hologic Inc., the Community Memorial Foundation, the Coleman Foundation and Quest Diagnostics.

For more information:

Related Content

Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Women With Coronary Artery Wall Thickness at Risk for Heart Disease
News | Cardiac Imaging | April 25, 2019
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for...
The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use

The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.